At its very simplest , this is it : Chimerix is going full speed ahead to get the drug on the market hopefully by the end of 2016 , and if they spend time and money on compassionate use cases , it would greatly hinder their effort to get the drug , brincidofovir , on the market and available to everyone . Josh Johnson is in critical condition at St. Jude 's Children 's Research Hospital . There is a drug that may help him , but the drug company is refusing . The company 's CEO says he has kids too and feels for Josh 's safety . Helping Josh and others like him makes slow efforts to get the drug on the market .
Josh Johnson is in critical condition at St. Jude 's Children 's Research Hospital . There is a drug that may help him , but the drug company is refusing . The company 's CEO says he has kids too and feels for Josh 's safety . Helping Josh and others like him makes slow efforts to get the drug on the market .